11:00:20 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

2025-02-13 Bokslutskommuniké 2024
2024-11-28 Kvartalsrapport 2024-Q3
2024-08-29 Kvartalsrapport 2024-Q2
2024-05-30 Kvartalsrapport 2024-Q1
2024-05-23 Årsstämma 2024
2024-05-17 Ordinarie utdelning OPTI 0.00 SEK
2024-03-15 Extra Bolagsstämma 2024
2024-02-27 Bokslutskommuniké 2023
2023-11-28 Kvartalsrapport 2023-Q3
2023-10-05 Extra Bolagsstämma 2023
2023-08-29 Kvartalsrapport 2023-Q2
2023-05-05 Kvartalsrapport 2023-Q1
2023-03-09 Ordinarie utdelning OPTI 0.00 SEK
2023-03-08 Årsstämma 2023
2023-02-14 Bokslutskommuniké 2022
2022-11-23 Extra Bolagsstämma 2022
2022-11-15 Kvartalsrapport 2022-Q3
2022-08-16 Kvartalsrapport 2022-Q2
2022-05-27 Ordinarie utdelning OPTI 0.00 SEK
2022-05-25 Årsstämma 2022
2022-05-06 Kvartalsrapport 2022-Q1
2022-02-09 Bokslutskommuniké 2021
2021-11-16 Kvartalsrapport 2021-Q3
2021-08-31 Kvartalsrapport 2021-Q2
2021-06-28 Årsstämma 2021
2021-05-28 Kvartalsrapport 2021-Q1
2021-05-14 Ordinarie utdelning OPTI 0.00 SEK
2021-03-05 Extra Bolagsstämma 2021
2021-02-16 Bokslutskommuniké 2020
2020-11-06 Kvartalsrapport 2020-Q3
2020-08-18 Kvartalsrapport 2020-Q2
2020-05-15 Ordinarie utdelning OPTI 0.00 SEK
2020-05-14 Årsstämma 2020
2020-05-05 Kvartalsrapport 2020-Q1
2020-02-14 Bokslutskommuniké 2019
2019-11-28 Kvartalsrapport 2019-Q3
2019-08-29 Kvartalsrapport 2019-Q2
2019-08-22 Extra Bolagsstämma 2019
2019-05-23 Kvartalsrapport 2019-Q1
2019-04-12 Ordinarie utdelning OPTI 0.00 SEK
2019-04-11 Årsstämma 2019
2019-02-14 Bokslutskommuniké 2018
2018-11-29 Kvartalsrapport 2018-Q3
2018-08-29 Kvartalsrapport 2018-Q2
2018-05-24 Kvartalsrapport 2018-Q1
2018-04-25 Ordinarie utdelning OPTI 0.00 SEK
2018-04-24 Årsstämma 2018
2018-02-15 Bokslutskommuniké 2017
2017-11-29 Kvartalsrapport 2017-Q3
2017-08-29 Kvartalsrapport 2017-Q2
2017-05-30 Kvartalsrapport 2017-Q1
2017-03-15 Ordinarie utdelning OPTI 0.00 SEK
2017-03-14 Årsstämma 2017
2017-02-17 Bokslutskommuniké 2016
2016-11-24 Kvartalsrapport 2016-Q3
2016-08-26 Kvartalsrapport 2016-Q2
2016-05-26 Kvartalsrapport 2016-Q1
2016-04-29 Ordinarie utdelning OPTI 0.00 SEK
2016-04-26 Årsstämma 2016
2016-02-25 Bokslutskommuniké 2015
2015-11-26 Kvartalsrapport 2015-Q3
2015-08-27 Kvartalsrapport 2015-Q2
2015-05-28 Kvartalsrapport 2015-Q1
2015-04-29 Ordinarie utdelning OPTI 0.00 SEK
2015-04-28 Årsstämma 2015
2015-02-26 Bokslutskommuniké 2014
2014-11-26 Kvartalsrapport 2014-Q3
2014-11-17 Extra Bolagsstämma 2014
2014-08-29 Kvartalsrapport 2014-Q2

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorMaterial
IndustriForskning & Utveckling
OptiCept Technologies förser livsmedels-och växtindustrin med teknologiska lösningar som används för att öka hållbarheten för diverse råvaror. Bolaget arbetar med biologiska processer som ger en ökad extraktion ur råvaran, minskat avfall samt bibehållen smak, doft, färg, näringsinnehåll. Bolaget har en patenterad teknologi inom PEF (pulsed electric field) och VI (Vacuum Infusion). Bolaget säljer sina produkter på en global nivå och har sitt huvudkontor i Lund.
2023-10-02 12:52:00

OptiCept Technologies AB (publ) ("OptiCept" or the "Company") today announces the outcome of the exercise of warrants of series TO6, which were issued in connection with the Company's rights issue of units during the fourth quarter of 2022. In total, 1,181,470 warrants of series TO6 were exercised, corresponding to approximately 85.6 percent of the total number of outstanding warrants of series TO6, for subscription of 1,181,470 shares at a subscription price of SEK 2.70 per share. OptiCept will receive approximately SEK 3.2 million before issuing costs through the exercise of the warrants of series TO6.

Background:
The subscription period for exercise of the warrants of series TO6 took place during the period from and including 18 September 2023, up to and including 29 September 2023. The subscription price per share for exercising the warrants of series TO6 was set to SEK 2.70.

In total, 1,181,470 warrants of series TO6 were exercised for subscription of 1,181,470 shares, meaning that approximately 85.6 percent of all outstanding warrants of series TO6 were exercised for subscription of shares.

Shares that have been subscribed and paid for will be registered on the subscriber's securities depository as interim shares (IA) until registration of the issue has been completed with the Swedish Companies Registration Office, whereupon the interim shares automatically will be converted into shares in OptiCept.

Number of shares, share capital and dilution:
Through the exercise of the warrants of series TO6, the number of shares in OptiCept increases by 1,181,470 shares, from 30,843,265 shares to a total of 32,024,735 shares. The share capital will increase by SEK 106,332.30, from SEK 2,775,893.85 to SEK 2,882,226.15.

For existing shareholders who did not exercise any warrants of series TO6, the dilution amounts to approximately 3.7 percent of the number of shares and votes in the Company.

Advisers
Pareto Securities AB acts as Sole Manager and Bookrunner, and Moll Wendén Advokatbyrå AB is legal adviser to the Company in connection with the exercise of warrants.